The societal cost of depression: Evidence from 10,000 Swedish patients in psychiatric care

• Published in: Journal of affective disorders 2013-09, Vol.150 (3), p.790-797
• Main Authors: Ekman, M, Granström, O, Omérov, S, Jacob, J, Landén, M
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Adult and adolescent clinical studies; Affective disorders; Aged; Aged, 80 and over; Ambulatory Care - economics; Anxiety-Depression; Biological and medical sciences; Burden-of-illness; Comorbidity; Cost; Cost of Illness; Depression; Depressive Disorder, Major - economics; DISORDERS; ECONOMIC BURDEN; EPISODES; EUROPE; Female; Health Care Costs; Health Resources - economics; Hospitalization; Hospitalization - economics; Humans; Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi; Hälsovetenskap; International Classification of Diseases - standards; Klinisk medicin; Male; Medical sciences; Medicin och hälsovetenskap; Mental health services; Mentally ill people; Middle Aged; Mood disorders; OF-ILLNESS; OUTCOMES; OUTPATIENTS; POPULATION; Primary health care; Primary Health Care - economics; Psychiatry; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psykiatri; Resource use; Retrospective Studies; Sick Leave - economics; STAR-ASTERISK-D; SWEDEN; Sweden - epidemiology; Young Adult
• ISSN: 0165-0327; 1573-2517; 1573-2517
• DOI: 10.1016/j.jad.2013.03.003

Abstract Objective Depression cost studies have mainly taken a primary care perspective and should be completed with cost estimates from psychiatric care. The objectives of this study were to estimate the societal per-patient cost of depression in specialized psychiatric care in Sweden, and to relate costs to disease severity, depressive episodes, hospitalization, and patient functioning. Methods Retrospective resource use data in inpatient and outpatient care for 2006–2008, as well as ICD-10 diagnoses and Global Assessment of Functioning (GAF), were obtained from the Northern Stockholm psychiatric clinic (covering half of Stockholm's population aged 18 years and above). As a complement, data from national registers on pharmaceuticals and sick leave were used in order to estimate the societal cost of depression. Results Based on 10,430 patients (63% women), the mean annual per-patient cost was €17, 279 in 2008. The largest cost item was indirect costs due to productivity losses (88%), followed by outpatient care (6%). Patients with mild and severe depression had average costs of €14,200 and €21,500, respectively. Total costs were substantially higher during depressive episodes, among patients with co-morbid psychosis or anxiety, for hospitalized patients, and for patients with poor functioning. Limitations Primary care costs and costs for reduced productivity at work were not included. Conclusions The main cost item among depression patients in psychiatric care was indirect costs. Costs were higher than previously reported for primary care, and strongly related to hospitalization, depressive episodes, and low functioning. This suggests that effective treatment that avoids depressive episodes and hospitalization may reduce society's costs for depression.